Vetoquinol - Asset Resilience Ratio

Latest as of June 2025: 1.45%

Vetoquinol (VETO) has an Asset Resilience Ratio of 1.45% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read VETO total debt and obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€10.53 Million

≈ $12.31 Million USD Cash + Short-term Investments

Total Assets

€725.82 Million

≈ $848.56 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2024)

This chart shows how Vetoquinol's Asset Resilience Ratio has changed over time. See VETO cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Vetoquinol's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Vetoquinol asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€10.53 Million	1.45%
Total Liquid Assets	€10.53 Million	1.45%

Asset Resilience Insights

Limited Liquidity: Vetoquinol maintains only 1.45% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Vetoquinol Industry Peers by Asset Resilience Ratio

Compare Vetoquinol's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Hunan Warrant Pharmaceutical Co. Ltd. A SHG:688799	Drug Manufacturers - Specialty & Generic	0.40%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Luye Pharma Group Ltd F:LUP	Drug Manufacturers - Specialty & Generic	9.15%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	2.98%
Shanxi Zhendong Pharmaceutical SHE:300158	Drug Manufacturers - Specialty & Generic	10.74%

Annual Asset Resilience Ratio for Vetoquinol (2005–2024)

The table below shows the annual Asset Resilience Ratio data for Vetoquinol.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.80%	€20.82 Million ≈ $24.34 Million	€744.13 Million ≈ $869.97 Million	+2.99pp
2023-12-31	-0.19%	€-1.32 Million ≈ $-1.55 Million	€692.23 Million ≈ $809.29 Million	-4.53pp
2022-12-31	4.34%	€28.28 Million ≈ $33.06 Million	€651.85 Million ≈ $762.08 Million	+1.88pp
2021-12-31	2.46%	€15.34 Million ≈ $17.93 Million	€624.56 Million ≈ $730.18 Million	+2.46pp
2020-12-31	0.00%	€1.00K ≈ $1.17K	€646.09 Million ≈ $755.35 Million	-3.62pp
2019-12-31	3.62%	€18.51 Million ≈ $21.64 Million	€511.47 Million ≈ $597.96 Million	-9.09pp
2018-12-31	12.71%	€59.17 Million ≈ $69.18 Million	€465.58 Million ≈ $544.32 Million	+3.94pp
2017-12-31	8.77%	€38.95 Million ≈ $45.53 Million	€443.97 Million ≈ $519.05 Million	+0.64pp
2016-12-31	8.13%	€35.71 Million ≈ $41.75 Million	€439.17 Million ≈ $513.44 Million	+8.21pp
2012-12-31	-0.07%	€-261.00K ≈ $-305.14K	€356.44 Million ≈ $416.71 Million	-0.07pp
2006-12-31	0.00%	€-3.00K ≈ $-3.51K	€210.62 Million ≈ $246.24 Million	+0.00pp
2005-12-31	0.00%	€-4.00K ≈ $-4.68K	€199.72 Million ≈ $233.49 Million	--

pp = percentage points

About Vetoquinol

PA:VETO France Drug Manufacturers - Specialty & Generic

Market Cap

$1.06 Billion

€902.66 Million EUR

Market Cap Rank

#8773 Global

#140 in France

Share Price

€76.50

Change (1 day)

+0.66%

52-Week Range

€66.10 - €91.00

All Time High

€149.34